In cholangiocarcinoma, inhibiting miR-24 increases menin expression, increases fibrosis, decreases pro-angiogenic gene expression, and decreases tumor xenograft growth [231], consistent with its role as a negative regulator of menin. Here, MEN1 is linked to neoplasm.